Study shows diabetes drug improves PromarkerD risk scores
Filed with ASX · · 4 pages · English
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Reinstatement to Official Quotation
- Suspension from Official Quotation
- Modelling shows PromarkerD could save US payers $384 billion
- Proteomics secures major analytical services contract
- Major economic health benefit demonstrated for PromarkerD
Later from Proteomics International Laboratories
- Proteomics engages Abcam to manufacture PromarkerD reagents
- June 2021 Quarterly Activities Report and Appendix 4C
- Proteomics to collaborate to validate test for endometriosis
- Proteomics contracts Biotem to manufacture PromarkerD kits
- Clinical utility study shows benefit of PromarkerD testing
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories